Eton Pharmaceuticals, Inc. (ETON)
$53.33-3.48%Close
SELLRECOVERY · day 5
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1.5B
- Beta
- 0.90
- P/E (TTM)
- 114.69
- Short % float
- 8.71%
- Days to cover
- 2.9
- SI change
- +18.9%
- 1W
- -2.63%
- 1M
- -7.45%
- vs SPY 1W
- -2.49%
- vs SPY 1M
- -9.95%
Industry peers
FMP comparable companies · ranked by market cap
- IONSSELLIonis Pharmaceuticals, Inc.$7.3BCRISISQ 8$44.16-2.95%
- TVTXSELLTravere Therapeutics, Inc.$5.0BCRISISQ 33$53.44-0.42%
- RAREBUYUltragenyx Pharmaceutical Inc.$1.5BRECOVERYQ -6$14.89-2.48%
- LXRXSELLLexicon Pharmaceuticals, Inc.$782MCRISISQ 5$1.76-2.42%
- PHARSELLPharming Group N.V.$683MCRISISQ -1$9.65-1.77%
- ZVRASELLZevra Therapeutics, Inc.$655MCRISISQ -8$11.08-8.22%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 56
- VALUE
- 17
- GROWTH
- 38
- GARP
- 73
- TYPE
- Growth Compounder
Composite of Value · Growth · GARP
ROIC24.1%
REV YoY-
ROE40.1%
EPS YoY-
ROA11.0%
GROSS58
OP15
NET12
[VALUATION]
P/E TTM114.69
P/E FWD28.74
SECTOR PE20.34
INDUSTRY PE19.31
P/B31.64
P/FCF-
EV/EBITDA73.33
EV/EBIT-
PEG0.59
FCF YIELD-
RISK
INT COV-
D/E62.22
ALTMAN Z-
CURR RATIO1.52
ND/EBITDA-
BETA0.90
Company news
FAQ
- What is LOPJLB’s current signal on ETON?
- LOPJLB’s latest quantitative signal on Eton Pharmaceuticals, Inc. (ETON) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is ETON in?
- Eton Pharmaceuticals, Inc. (ETON) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Eton Pharmaceuticals, Inc. (ETON) do?
- Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid fo…